
Free Daily Podcast Summary
by Veeva
State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
The most recent episodes — sign up to get AI-powered summaries of each one.
In this special episode, Manny sits in the guest’s chair and shares his journey from Veeva to Merck. He and host Drew Garty explore what it truly takes to drive change management within big pharma, the challenge of breaking entrenched habits, and why real innovation requires empowering a new generation of data managers to look at legacy processes with a clean slate. From cracking longstanding industry hurdles like local lab normative ranges to leveraging AI and native tech skills, they discuss how fresh perspectives from incoming talent will shape the future of clinical trials.
Manny is joined by guest Jack Evans, VP Europe at Civia Health, to discuss the operational realities, systemic burdens, and collaborative opportunities between clinical trial sponsors, CROs, and research sites. Jack highlights the challenges of setting up a research site in Europe, and what they need from sponsors to help make clinical trials more efficient.
In this episode Danielle Drachmann, CEO of Ketotic Hypoglycemia International, and Senior Patient Partnering Manager at Thermo Fisher Scientific, explains how lived experience can – and should – reshape clinical research from day one. Danielle shares her powerful personal journey from kindergarten teacher to founder of a global rare disease organization after fighting for answers for her children.
In this episode, Novo Nordisk’s Rhona O'Donnell and Ibrahim Kamstrup-Akkaoui explore how the combination of open source tools and AI is reshaping the future of clinical data management. From the creation of OpenStudyBuilder to the potential of Veeva’s agentic AI layer, they discuss breaking down traditional industry silos to get treatments to patients faster.
In this episode of Unblinded, host Manny Vazquez is joined by Leianne Ebert, Head of Data Operations at Alcon, and co-host John Acampado, Senior Director of Clinical Strategy for Veeva MedTech. Together, they explore the regulatory differences between pharma and medical device trials, data standards, and the industry’s digital maturity. Leianne and John also provide a reality check on AI readiness, debating the "deep pockets, short arms" mentality of the industry, and end with a call to action for systemic technology adoption.
Joel White, owner of Marketcap Consulting, together with Veeva’s Chris Kreitel, joins Manny to discuss why the next era of clinical trial outsourcing will be defined by technology integration and economic agility. They debate whether CROs are the ultimate masters of integrating tech, and the role of small biotechs as growth drivers in the market.
In this episode, host Manny Vazquez is joined by Noeleen Turner, head of clinical data management at UCB, and Anna Hayes, senior director of clinical data management at Veramed. Using their breadth of experience and passion for a people-focused approach to clinical trial advancement, together they dive into hot topics like risk-based data management, the intricacies of change management in clinical data, and the growing importance of endpoint-driven design.
In this episode, we pull back the curtain on the monumental effort required to reshape global clinical trial standards. Manny and guests Lisbeth Bregnhoj and Cheryl Grandinetti explore why ICH E6(R3) is the catalyst the industry has been waiting for. From the intense complexity of dialing in language across regional borders to the latest push for a truly risk-based approach to clinical trials, the discussion highlights: A shift in strategy: Why the industry is finally moving away from "one-size-fits-all" in favor of flexibility and high-level data governance Defining quality: Breaking down what Critical-to-Quality (CtQ) factors actually look like in practice and how to align that understanding between sponsors, service providers, and investigators The future of inspections: It’s not just a change for sponsors – regulators are also facing a major shift in how they harmonize inspection techniques in a risk-based world
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

ICU Ed and Todd-Cast
Eddie and Todd

The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.

FDA Watch
A regulatory expert hosts discussions on FDA policies and developments across pharmaceuticals, devices, food, and cosmetics.

Solutions with Henry Blodget
Henry Blodget interviews experts in business, tech, and politics about practical solutions for building a better future.

The VPZD Show
Two physicians discuss healthcare, medicine, and policy from a contrarian, middle-ground perspective.

The Deep View: Conversations
Discusses AI advancements and leadership with innovators from labs, enterprises, and startups shaping the industry.

Health Discovered
Doctors explore surprising stories to uncover insights about health and well-being.

The AI in Business Podcast
Interviews with AI executives reveal practical applications and strategic insights for business leaders adopting AI.

The AI XR Podcast
Insightful interviews with tech founders and executives on AI, virtual reality, augmented reality, and the future of spatial computing.

Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.

The Restless Ones
Executives at the intersection of technology and business discuss innovation, leadership, and driving change in fast-evolving industries.

A Shot in the Arm Podcast
Ben Plumley
State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Unblinded: A Clinical Trial Podcast in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Unblinded: A Clinical Trial Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Veeva.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
Unblinded: A Clinical Trial Podcast publishes monthly. Our AI generates a summary within hours of each new episode.
Unblinded: A Clinical Trial Podcast covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.